Unresectable HCC with Extrahepatic Involvement

EP. 1: Approaching a Case of Unresectable HCC with Extrahepatic Involvement

November 29th 2018

EP. 2: Unresectable HCC: Considerations for Resection and Frontline Therapy

November 29th 2018

EP. 3: Reviewing Lenvatinib Data for Treatment in mHCC

November 29th 2018

EP. 4: Balancing Efficacy With Toxicity Among the Agents for HCC

November 29th 2018

EP. 5: Patient Factors in Choosing Optimal Agents in HCC Therapy

November 29th 2018

Trending on Targeted Onc

Lonardi on Overall Survival With Nivolumab/Ipilimumab in MSI-H/dMMR mCRC

JNJ-6143 Elicits PSA Responses in Heavily Pretreated mCRPC

Chidamide Plus Nivolumab Shows Potential Frontline Role in Melanoma

BMI Limitations Complicate Obesity and Cancer Research

Petosemtamab Plus Pembrolizumab Improves OS in PD-L1+ HNSCC